Cells . Identification of Cellular Factors Required for SARS-CoV-2 Replication

[tetano]

Cells


. 2021 Nov 13;10(11):3159.
doi: 10.3390/cells10113159.
Identification of Cellular Factors Required for SARS-CoV-2 Replication


Aleksandra Synowiec ¹ , Malwina Jedrysik ¹ , Wojciech Branicki ² , Adrianna Klajmon ² , Jing Lei ³ , Katarzyna Owczarek ¹ , Chen Suo ^{3 4} , Artur Szczepanski ^{1 5} , Jingru Wang ³ , Pengyan Zhang ³ , Pawel P Labaj ⁶ , Krzysztof Pyrc ¹



Affiliations

• PMID: 34831382
• DOI: 10.3390/cells10113159

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the recently emerged virus responsible for the COVID-19 pandemic. Clinical presentation can range from asymptomatic disease and mild respiratory tract infection to severe disease with lung injury, multiorgan failure, and death. SARS-CoV-2 is the third animal coronavirus to emerge in humans in the 21st century, and coronaviruses appear to possess a unique ability to cross borders between species and infect a wide range of organisms. This is somewhat surprising as, except for the requirement of host cell receptors, cell-pathogen interactions are usually species-specific. Insights into these host-virus interactions will provide a deeper understanding of the process of SARS-CoV-2 infection and provide a means for the design and development of antiviral agents. In this study, we describe a complex analysis of SARS-CoV-2 infection using a genome-wide CRISPR-Cas9 knock-out system in HeLa cells overexpressing entry receptor angiotensin-converting enzyme 2 (ACE2). This platform allows for the identification of factors required for viral replication. This study was designed to include a high number of replicates (48 replicates; 16 biological repeats with 3 technical replicates each) to prevent data instability, remove sources of bias, and allow multifactorial bioinformatic analyses in order to study the resulting interaction network. The results obtained provide an interesting insight into the replication mechanisms of SARS-CoV-2.

Keywords: CRISPR-Cas9; SARS-CoV-2; cellular factors; coronavirus; mechanisms of infection; viral pathogenesis.